Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

U.S. Department of Health and Human Services secretary Robert F. Kennedy, Jr announced on Tuesday that COVID vaccines will be ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

Universal immunisation with nirsevimab significantly reduces hospitalizations and paediatric intensive care admissions for ...

A new study reveals that respiratory syncytial virus (RSV) hospitalizations have significantly higher risks for heart ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic ...

The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...